Cardinal Health Inc
$ 216.26
1.69%
10 Jun - close price
- Market Cap 47,890,412,000 USD
- Current Price $ 216.26
- High / Low $ 218.96 / 211.50
- Stock P/E 31.27
- Book Value -12.05
- EPS 6.54
- Next Earning Report 2026-08-18
- Dividend Per Share $2.04
- Dividend Yield 0.99 %
- Next Dividend Date 2026-07-15
- ROA 0.04 %
- ROE N/A %
- 52 Week High 233.04
- 52 Week Low 136.63
About
Cardinal Health, Inc. is an American multinational health care services company.
Analyst Target Price
$245.27
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-02-05 | 2025-10-30 | 2025-08-12 | 2025-05-01 | 2025-01-30 | 2024-11-01 | 2024-08-14 | 2024-05-02 | 2024-02-01 | 2023-11-03 | 2023-08-15 |
| Reported EPS | 1.69 | 1.97 | 2.55 | 2.08 | 2.1 | 1.65 | 1.88 | 1.84 | 2.08 | 1.82 | 1.73 | 1.55 |
| Estimated EPS | 2.34 | 1.92 | 2.17 | 2.03 | 1.69 | 1.5 | 1.62 | 1.73 | 1.95 | 1.6 | 1.41 | 1.48 |
| Surprise | -0.65 | 0.05 | 0.38 | 0.05 | 0.41 | 0.15 | 0.26 | 0.11 | 0.13 | 0.22 | 0.32 | 0.07 |
| Surprise Percentage | -27.7778% | 2.6042% | 17.5115% | 2.4631% | 24.2604% | 10% | 16.0494% | 6.3584% | 6.6667% | 13.75% | 22.695% | 4.7297% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-18 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 2.41 |
| Currency | USD |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-15 | 2026-01-15 | 2025-10-15 | 2025-07-15 | 2025-04-15 | 2025-01-15 | 2024-10-15 | 2024-07-15 | 2024-04-15 | 2024-01-15 |
| Amount | $0.5107 | $0.5107 | $0.5107 | $0.5107 | $0.5056 | $0.5056 | $0.5056 | $0.5056 | $0.5006 | $0.5006 |
Next Dividend Records
| Dividend per share (year): | $2.04 |
| Dividend Yield | 0.99% |
| Next Dividend Date | 2026-07-15 |
| Ex-Dividend Date | 2026-07-01 |
Recent News: CAH
2026-06-10 14:37:10
Barclays has reiterated its Buy rating on Cardinal Health (CAH.US) and maintained its price target at $258. This decision reflects the firm's continued positive outlook on the company's financial performance and market position.
2026-06-09 16:51:00
Cardinal Health Inc. (CAH) stock rose 4.01% to $212.67 on Tuesday, outperforming a mixed stock market. The Dow Jones Industrial Average saw a slight increase, while the S&P 500 Index declined. Despite the gain, Cardinal Health Inc. remains 8.96% below its 52-week high.
2026-06-09 15:24:03
Vertex Pharmaceuticals is strengthening its position in the cystic fibrosis market through new pediatric ALYFTREK data, TRIKAFTA regulatory progress, and ongoing pipeline diversification. The company's future growth hinges on regulatory decisions, pediatric label language, safety updates, and broader pipeline advancements. These developments are key to extending its competitive edge in healthcare.
2026-06-08 22:08:43
Onconetix (ONCO) has filed an S-1 registration statement for a potential 100 million share equity line of credit with Keystone Capital Partners, intended for resale, despite having only 3.69 million shares outstanding, indicating severe potential dilution for existing shareholders. The company disclosed substantial doubt about its ability to continue as a going concern, reporting a $15.5 million net loss in 2025 and an accumulated deficit of $135.4 million, with cash balances of $3.7 million at March 31, 2026, and $6.5 million at June 5, 2026. Onconetix is focusing on commercializing its prostate cancer diagnostic test, Proclarix, and has a pending share exchange agreement with Realbotix Corp. which could transfer 75-90% of fully diluted ownership, depending on net cash.
2026-06-08 20:39:59
Mission Produce, Inc. (AVO) reported Q2 revenue of $290.9 million, surpassing FactSet's estimate of $256.3 million. This financial update indicates a stronger-than-expected revenue performance for the company during the second quarter. The report highlights the company's financial results and provides context against analyst expectations.
2026-06-08 20:02:13
This article announces an SEC Form 144 filing by Cardinal Health Inc. (CAH), indicating a proposed sale of securities under Rule 144. The filing provides details about the securities to be sold, including their acquisition date, nature of acquisition (restricted stock vesting), and the number of shares. This report is categorized as neutral in both impact and sentiment.
